Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Anticancer Research
|
December 17, 1998
Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients
G Cavaletti, G Bogliun, A Zincone, et al.
Cancer Gene Therapy
|
January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
M Di Nicola, S Siena, M Bregni, et al.
Bone Marrow Transplantation
|
January 10, 2006
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer
M Bregni, K Fleischhauer, M Bernardi, et al.
British Journal of Cancer
|
March 30, 2006
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study
C Bengala, C Zamagni, P Pedrazzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results
A M Gianni, S Siena, M Bregni, et al.
Bone Marrow Transplantation
|
November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
R Crocchiolo, O Ringden, J-O Bay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies
A Zambelli, D Lilleri, P Pedrazzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
P Corradini, F Zallio, J Mariotti, et al.
Bone Marrow Transplantation
|
July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
P Ljungman, M Bregni, M Brune, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
L Barkholt, M Bregni, M Remberger, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Anticancer Research
|
December 17, 1998
Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients
G Cavaletti, G Bogliun, A Zincone, et al.
Cancer Gene Therapy
|
January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
M Di Nicola, S Siena, M Bregni, et al.
Bone Marrow Transplantation
|
January 10, 2006
Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer
M Bregni, K Fleischhauer, M Bernardi, et al.
British Journal of Cancer
|
March 30, 2006
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study
C Bengala, C Zamagni, P Pedrazzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results
A M Gianni, S Siena, M Bregni, et al.
Bone Marrow Transplantation
|
November 14, 2017
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
R Crocchiolo, O Ringden, J-O Bay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies
A Zambelli, D Lilleri, P Pedrazzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
P Corradini, F Zallio, J Mariotti, et al.
Bone Marrow Transplantation
|
July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
P Ljungman, M Bregni, M Brune, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2006
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
L Barkholt, M Bregni, M Remberger, et al.
Page
of 11